Insider Transactions Reported by 28 Insiders of Carisma Therapeutics Inc.

Symbol
CARM on OTC
Location
Philadelphia, PA

Insiders trading volume in the past year

Carisma Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ModernaTX, Inc. 10%+ Owner $2,969,831 07 Mar 2023
Regina Hodits Director $1,348,660 07 Mar 2023
Thomas R. Cannell President and CEO, Director $394,691 02 Mar 2023
Minori Rosales Chief Development Officer $365,701 24 Jan 2022
Monica Forbes Chief Financial Officer $296,825 02 Mar 2023
Glen C. MacDonald Chief Technology Officer $234,165 02 Mar 2023
Mark Sullivan General Counsel & Secretary $222,268 02 Mar 2023
Elly Ryu Principal Accounting Officer $87,242 02 Mar 2023
Peter Honig Director $23,480 22 Jun 2022
Carrie L. Bourdow Director $23,480 22 Jun 2022
Michael A. S. Jewett Director $23,480 22 Jun 2022
Jason A. Keyes Director $23,480 22 Jun 2022
Jay S. Duker Director $23,480 22 Jun 2022
Michael Klichinsky Chief Scientific Officer $0 -$138,828 -100% 07 Oct 2025
Bjorn Odlander Director 07 Mar 2023
John Hohneker Director 26 Jun 2024
Natalie McAndrew Vice President of Finance 01 Jan 2025
Marella Thorell Director 01 Jul 2024
Sohanya Roshan Cheng Director 31 Oct 2024
Steven Kelly President and CEO, Director 28 Jan 2025
Briggs Morrison Director 26 Jun 2024
Michael Torok Director 26 Jun 2024
Chidozie Ugwumba Director 06 Jun 2023
Sanford S. Zweifach Director 26 Jun 2024
Richard Steven Morris Chief Financial Officer 17 Jun 2024
David Scadden Director 01 Jul 2024
Patricia M. Drake Chief Commercial Officer 01 Jun 2021
Jane Pritchett Henderson Director 03 May 2021

Recent Insider Transactions by Companies or Individuals for Carisma Therapeutics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Michael Klichinsky CARM Common Stock Sale -100% $14,485 $0.2542 -56,982 0 07 Oct 2025 Direct
Michael Klichinsky CARM Common Stock Options Exercise 56,982 56,982 07 Oct 2025 Direct
Michael Klichinsky CARM Stock Option (right to buy) Options Exercise -100% -56,982 0 07 Oct 2025 Direct
Michael Klichinsky CARM Common Stock Sale -100% $31,078 $0.2604 -119,347 0 03 Oct 2025 Direct
Michael Klichinsky CARM Common Stock Sale -62.6% $50,860 $0.2543 -200,000 119,347 02 Oct 2025 Direct
Michael Klichinsky CARM Common Stock Sale -34.1% $42,405 $0.2570 -165,000 319,347 01 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.